A member of Natco Pharma’s promoter group, Satya Vani Nannapaneni, has sold 23,000 equity shares in the open market. This transaction represents a minor change in shareholding. Post-sale, the promoter group continues to hold a significant stake in the company. The sale was conducted under insider trading regulations. This was announced on September 17, 2025.
Details of Share Disposal
Satya Vani Nannapaneni, a member of the promoter group of Natco Pharma, has disposed of 23,000 equity shares of the company in the open market. The transaction was completed on September 17, 2025.
Impact on Shareholding
Prior to the sale, Satya Vani Nannapaneni held 4,02,851 shares, representing 0.22% of the total share/voting capital. Following the sale of 23,000 shares, the promoter group member now holds 3,79,851 shares, which represents 0.21% of the total share/voting capital.
Transaction Details
The shares, with a face value of Rs. 2/- each, were sold through the open market. The transaction was carried out in compliance with insider trading regulations. The total equity share capital of Natco Pharma before and after the transaction remains unchanged at 17,91,09,870 equity shares.
Source: BSE
